The Globe and Mail reports in its Saturday, Oct. 12, edition that Jefferies analysts Ryan Tomkins and Owen Bennett made significant changes to target prices for Canadian marijuana producers on Friday, emphasizing price performance over the next 12 months will likely see a "strong divergence between those who can execute/move to profit and the rest." The Globe's David Leeder writes in the Eye On Equities column that the analysts said in a research note released Friday, "With a number of negative headlines impacting the sector the last six months, and still with little sign of profitability, the sector has seen greater risk/volatility priced in." Jefferies expects to see a number of smaller companies go bankrupt or face consolidation with larger names in the sector, as cash flow demand rises. The analysts cut their share target for Aurora Cannabis ($4.86) to $7 from $14. Analysts on average target the shares at $9.50. The Globe reported on Sept. 16 that Desjardins analyst John Chu reiterated his "buy" call for Aurora. The shares were then worth $7.26. The Globe reported on Sept. 17, that Stifel analyst Andrew Carter downgraded Aurora to "sell" from "hold." It was then worth $7.26.